Abstract
SUMMARY Diabetes is the fastest growing chronic disease worldwide. Conventional diagnostic tests, such as fasting plasma glucose, oral glucose tolerance test and glycosylated hemoglobin, are invasive and relatively expensive for application in low-income developing countries. Diabetes Risk Score has emerged as a practical screening tool during the past decade. The purpose of this review is to evaluate the components and validity of risk scores for the screening and early detection of Type 2 diabetes mellitus.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
